enced bleeding and vaso-occlusive complications, while 17.1% of the cases with clonal thrombocytosis did.
Platelet production is the result of a highly ordered maturation of a developmental hierarchy of megakaryocytic progenitor cells regulated by a variety of cytokines (1) . Of those cytokines, GM-CSF, II-3, and II-6 have a stimulatory effect while several cytokines including TGF-beta, platelet-released glycoprotein, platelet factor 4, and interferons have inhibitory effects down regulating platelet production perhaps as part of an autocrine control loop (1) . Increased platelet count or thrombocytosis, defined as a platelet count greater than or equal to 350 × 10 9 /L, is a common hematologic aberration seen in the complete blood cell count. Schafer said that thrombocytosis was caused by three major pathophysiologic mechanisms: (1) reactive or secondary thrombocytosis; (2) clonal thrombocytosis, in-cluding essential thrombocythemia and related myeloproliferative disorders; and (3) familial thrombocytosis (2) . There are several etiologies of thrombocytosis according to the described pathologic processes (2, 3) . However, in some cases, severe thrombocytosis can be seen. There are limited data on the etiology of this abnormality. A retrospective investigation for the etiology of extreme thrombocytosis was performed.
MATERIALS AND METHODS
This study was designed as a descriptive retrospective study. A literature review of the papers concerning the cases series on the extreme thrombocytosis was performed, using the database of published works cited in the Index Medicus (www.pubmed.com). The operative definition of extreme thrombocytosis is defined as a platelet count greater than or equal to 1,000 × 10 9 /L. According to the literature review, three reports (4-6) were recruited for further study. The details of etiologies of extreme thrombocytosis in 85 Extreme Thrombocytosis: What Are the Etiologies? Viroj Wiwanitkit, MD
Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Summary: Increase platelet count or thrombocytosis, defined as a platelet count greater than or equal to 350 × 10 9 /L, is a common hematologic aberration seen in complete blood cell count. Several etiologies are documented for thrombocytosis. Extreme thrombocytosis, defined as a platelet count greater than or equal to 1,000 × 10 9 /L, is rarely seen in general practice. There are limited data on the etiology of this abnormality. Here, a retrospective investigation for the etiology of severe thrombocytosis was performed. Of the 3 included reports, 535 cases with extreme thrombocytosis were investi-gated for their etiologies. The 2 defined etiologies are secondary thrombocytosis (66.6%) and clonal thrombocytosis. Of those cases with clonal thrombocytosis, 93.8% had myeloproliferative disorders, and 6.2% had essential thrombocytosis. Concerning bleeding and vaso-occlusive complications, all cases had these complications. In this study, 7.9% of the cases with secondary thrombocytosis experi-all included reports were studied. The demographic data of all cases including age, gender, and location were reviewed as well. Descriptive statistics, including range and percentage, were used in analyzing the patient characteristics and laboratory parameters for each group. All the statistical analyses in this study were made using SPSS 7.0 for Windows.
RESULTS
Of the three included reports, 535 cases with extreme thrombocytosis were investigated for their etiologies ( Table 1 ). The two defined etiologies are secondary thrombocytosis (66.6%) and clonal thrombocytosis (33.4%). Of those cases with clonal thrombocytosis, 93.8% had myeloproliferative disorders and 6.2% had essential thrombocytosis. In this study, 7.9% of the cases with secondary thrombocytosis experienced bleeding and vaso-occlusive complications while 17.1% of the cases with clonal thrombocytosis had complications.
DISCUSSION
The elevated platelet count has been implicated in the pathophysiology of many hemostatic problems (3) . It is proposed that bleeding and thrombosis could be due to vascular abnormalities that result from dysfunctional hematopoietic stem cell-derived endothelial cells (3) . Thrombocytosis can be sometimes seen in general practice. However, the severe or extreme thrombocytosis is rarely detected. Only a few reports con-cerning the etiologic study of extreme thrombocytosis have been published (4) (5) (6) .
According to this study, only two of three main etiologies for thrombocytosis are identified as causes of extreme thrombocytosis (2) . Secondary thrombocytosis (66.6%) is more common as an etiology for extreme thrombocytosis than clonal thrombocytosis (33.4%). This finding supports the previous finding of Chuncharunee and colleagues (4). However, it does not match with the proposal that extreme thrombocytosis in the patients is generally considered secondary to a myeloproliferative disease (7) . Concerning underlying causes of secondary thrombocytosis-based extreme thrombocytosis, several causes such as post-splenectomy, infection, and iron deficiency anemia were mentioned (4) (5) (6) .
Peripheral blood smear examination is not useful for differential diagnosis of the two etiologies for extreme thrombocytosis (8) . However, statistically significant differences between the bone marrow findings in myeloproliferative disorders and extreme reactive thrombocytosis were found in the numbers of megakaryocytes, presence or absence of megakaryocyte clusters, stainable iron, cellularity, and reticulin content (8) . Buss and associates concluded that bone marrow examination is a useful procedure as an aid in determining the cause of extreme thrombocytosis (8) . Concerning the underlying causes of clonal thrombocytosis-based extreme thrombocytosis, the myeloproliferative disorders are more common than essential thrombocytosis. Recently, Buss and colleagues found that the bone marrow findings in primary thrombocythemia were quite similar to those in poly- cythemia vera and chronic granulocytic leukemia with associated extreme thrombocytosis (8) .
Concerning the complications of extreme thrombocytosis, the two common complications of thrombocytosis, bleeding and thrombosis, can be seen as well. In this study, the cases with clonal thrombocytosis have a significantly higher chance of developing bleeding and vaso-occlusive complications than those with secondary thrombocytosis (p < 0.05). Because myeloproliferative disorders are the most common underlying cause of clonal thrombocytosis in patients with extreme thrombocytosis, this finding is expected.
